Last update 21 Nov 2024
ELGN-2112
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Hormone |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization  Elgan Pharma Ltd.Startup |
Active Organization Elgan Pharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with ELGN-2112A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Basket Study to Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Basket Study to Assess the Safety of ELGN-2112 in Populations of Interest - FIT-05
100 Clinical Results associated with ELGN-2112
Login to view more data
100 Translational Medicine associated with ELGN-2112
Login to view more data
100 Patents (Medical) associated with ELGN-2112
Login to view more data
100 Deals associated with ELGN-2112
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fetal Growth Retardation | Phase 2 | - | Elgan Pharma Ltd.Startup | 01 Sep 2023 |
| Malabsorption Syndromes | Phase 2 | - | Elgan Pharma Ltd.Startup | 01 Sep 2023 |
| Obstetric Labor, Premature | Phase 2 | - | Elgan Pharma Ltd.Startup | 01 Sep 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free